期刊文献+

肝内胆管癌23例临床特点和诊治分析 被引量:1

Analysis of Clinical Features, Diagnosis and Treatment of 23 Cases with Intrahepatic Cholangiocarcinoma
原文传递
导出
摘要 [目的]探讨肝内胆管癌的临床特点、诊治和预后,以进一步提高其诊治水平。[方法]回顾性分析1993年12月至2009年8月经病理证实的肝内胆管癌23例患者临床资料,其中19例经开腹手术,包括单纯肝脏活检术7例,姑息性手术9例,根治性切除术3例,另4例经影像学定位下经皮肝脏穿刺活检。[结果]全组临床表现无特异性,合并肝内胆管结石或有肝内胆管结石手术史者47.9%(11/23),伴肝硬化者8.7%(2/23),血清CA19-9明显升高者52.2%(12/23),B超、CT诊断符合率分别为39.1%(9/23)、81%(17/21)。保守或姑息手术治疗者1年生存率15%(3/20),3例行根治性手术者1年生存率100%(3/3)。[结论]肝内胆管癌无特异性临床表现,根治性手术可明显延长其生存期。
机构地区 衢州市中医医院
出处 《肿瘤学杂志》 CAS 2010年第12期983-984,共2页 Journal of Chinese Oncology
  • 相关文献

参考文献5

  • 1Yamamoto T, Takeuchi K, Okuda C, et al. Two small in- trahepatic cholangiocarcinomas with different sonographie appearances[J]. J Clin Ultrasound, 2001, 29(6):344-348.
  • 2Wu ZY, Luo M. New views upon intrahepatic cholangio- carcinoma [J]. Journal of Surgery Concepts & Practice, 2009, 14 (2):135-139.
  • 3陈平,何振平,别平,王曙光,蔡景修,董家鸿.肝内胆管结石合并肝内胆管癌的诊断和外科治疗[J].中华肝胆外科杂志,2003,9(12):762-764. 被引量:9
  • 4Loyer EM, Chin H, DuBrow RA, et al. Hepatocellular car- cinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple helical CT--a com- parative study[J]. Radiology, 1999, 212(3):866-875.
  • 5左朝晖,欧阳永忠,罗建红,等.肝内胆管癌的治疗和预后因素的分析[A].第一届全国胆管肝癌学术会议论文集[C].2009.190.

二级参考文献2

  • 1R.W. Chapman. Risk Factors for Biliary Tract Carcinogenesis[J] 1999,Annals of Oncology(4):308~311
  • 2Yasuni Nakanuma,Tadashi Terada,Yoshinori Tanaka,Goroku Ohta. Are hepatolithiasis and cholangiocarcinoma aetiologically related?[J] 1985,Virchows Archiv A Pathological Anatomy and Histopathology(1):45~58

共引文献8

同被引文献12

  • 1周学平,杨广顺,丛文铭,卢军华,张树辉,宗明.原发性肝癌瘤周肝组织内微转移的回顾性与前瞻性研究[J].中华肝胆外科杂志,2005,11(8):510-514. 被引量:19
  • 2Khan SA,Thomas HC,Davidson BR,et al.Cholangiocarci- noma[J]. Lancet, 2005,366(9493): 1303-1314.
  • 3Yang J,Yan LN. Current status of intrahepatic cholangiocar- cinoma[J].World J Gastroenterol,2008,14(4 I): 6289-6297.
  • 4Endo I,Gonen M,Yopp AC,et al. Intrahepatic cholangio- carcinoma: rising frequency, improved survival', and deter-minants of outcome after resection[J]. Ann Surg, 2008,248 (1):84-96.
  • 5Osaki T,Oyama T,Gu CD,et al. Prognostic impact of mi- crometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non- small-cell lung cancer [J]. J Clin Oncol , 2002 , 20 (13): 2930-2936.
  • 6Suzuki S,Sakaguchi T,Yokoi Y,et al. Clinicopathological prognostic factors and impact of surgic, al treatment of mass-forming intrahepatic cholangiocarcinoma[J]. WoAd J Surg, 2002,26(6):687-693.
  • 7Nakagohri T,Kinoshita T,Konishi M,et al. Surgical out- come and prognostic factors in intrahepatic cholangiocar- einoma[J]. Worht J Surg,2008,32(12):2675-2680.
  • 8Heron DE,Stein DE,Eschelman DJ,et al. Cholangiocarci- noma: the impact of tumor location and treatment strategy on outcome[J]. Am J Clin Oncol,2003,26(4):422-428.
  • 9Aljiffry M,Abdulelah A,Walsh M,et al. Evidence-based approaeh to cholangiocarcinoma: a systematic review of the current literature[J]. J Am Coll Surg,2009,208(1): 134-147.
  • 10Cho SY,Park SJ,Kim SH,et al.Survival analysis of intra- hepatic cholangiocarcinoma after resection[J]. Ann Surg On- col,2010, 17(7): 1823-1830.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部